Nektar Therapeutics (NKTR) Work In Process (2011 - 2024)

Nektar Therapeutics' Work In Process history runs 12 years deep, the most recent figure standing at $10.6 million for Q2 2024.

• On a quarterly basis, Work In Process changed N/A year-over-year to $10.6 million in Q2 2024; TTM through Jun 2024 was $10.6 million, a N/A change from a year earlier, with the FY2023 full-year figure at $12.9 million, up 19.83% from the prior year.
• Work In Process advanced to $10.6 million in Q2 2024 per NKTR's latest filing, from $10.0 million in the prior quarter.
• Across five years, Work In Process topped out at $12.9 million in Q4 2023 and bottomed at $10.0 million in Q1 2024.
• The 3-year median for Work In Process is $10.7 million (2022), against an average of $11.3 million.
• Biggest YoY gain for Work In Process was 19.83% in 2023; the steepest drop was 19.83% in 2023.
• Year by year, Work In Process stood at $10.7 million in 2022, then grew by 19.83% to $12.9 million in 2023, then fell by 17.78% to $10.6 million in 2024.
• Per Business Quant, the three latest NKTR Work In Process figures stand at $10.6 million (Q2 2024), $10.0 million (Q1 2024), and $12.9 million (Q4 2023).